Background-Ganglioside GM3 mediates adipocyte insulin resistance, but the role of GM3 in diabetic wound healing, a major cause of morbidity, is unclear.
INTRODUCTION
Chronic cutaneous ulcerations affects 15% of individuals with type 2 diabetes (Reiber et al., 1998) , often leading to amputation. The poor wound healing in diabetes has been linked to impaired insulin receptor (IR)/insulin-like growth factor-1 receptor (IGF-1R) signaling, accumulation of glycosylated end products, vasculopathy, neuropathy, and infection (Acosta et al., 2008; Brem and Tomic-Canic, 2007; Christman et al., 2011; Guo and Dipietro, 2010; Markuson et al., 2009; Marston, 2006; Nouvong et al., 2009; Peppa and Vlassara, 2005) . While levels of glycosylated proteins are an accepted measure of glycemic control and their accumulation has been strongly linked to impaired acral wound healing in diabetics (Christman et al., 2011; Markuson et al., 2009) , little is known about the role of increased glycolipids in diabetic wound healing.
Wound healing is a complex process that requires the activation, migration and proliferation of keratinocytes (KCs) to re-epithelialize the wound. Although skin is not a classical insulin target tissue, both insulin and IGF-1 have been shown to be potent stimulants of normal KC migration and proliferation through activation of IR and IGF-1R (Ando and Jensen, 1993; Li et al., 2006) . Indeed, studies in IR-null and IGF-1R-null mice have shown both IR and IGF-1R to be essential for normal keratinocyte physiology (Sadagurski et al., 2006; Stachelscheid et al., 2008) . Nevertheless, the role of IR/IGF-1R signaling impairment in the compromised re-epithelialization of diabetic wounds is not well understood (Usui et al., 2008) .
Ganglioside GM3 has been suggested to play an intermediary role in the development of insulin resistance and diabetes. GM3, a sialylated membrane-based glycosphingolipid, and the enzyme that synthesizes it, GM3 synthase (GM3S; also called SAT-I/ ST3Gal-V), are increased in the kidneys, liver, adipose tissue and muscle of murine models of diabetes (Memon et al., 1999; Tagami et al., 2002; Zador et al., 1993) . Increased levels of gangliosides have been found in the serum of diabetic patients with microvascular complications (Hamed et al., 2011) , and GM3S expression is increased in the kidneys of diabetics with nephropathy (Wei et al., 2011) . Tumor necrosis factor alpha (TNF-α), which causes insulin resistance, increases GM3S and GM3 expression in canonical insulin target cells (adipocytes, myocytes and hepatocytes) (Memon et al., 1999; Tagami et al., 2002) . Glucosylceramide synthase inhibitors deplete GM3 and reverse TNF-α-induced suppression of IRS-1 tyrosine phosphorylation in adipocytes (Aerts et al., 2007; Tagami et al., 2002) . GM3 directly suppresses IR and IR substrate-1 (IRS-1) tyrosine phosphorylation in cultured adipocytes, decreasing glucose uptake (Tagami et al., 2002) . Knocking out GM3S in mice (Yamashita et al., 2003) and treatment of diabetic mice or rats with glucosylceramide synthase inhibitors improves insulin sensitivity (Aerts et al., 2007; Zhao et al., 2009; Zhao et al., 2007) , ameliorates hepatic steatosis (Zhao et al., 2009) , and suppresses the development of diabetic renal hypertrophy (Zador et al., 1993) . The impact of gangliosides on IGF-1R activation has never been explored.
We have found increased expression of GM3S in the foot skin of human diabetics and of GM3S and GM3 in the skin of diabetic mice. Knocking out GM3S and depleting GM3 fully prevented the wound healing impairment of diet-induced obese (DIO) mice. Keratinocytes from GM3S knockout mice have activated IR and IGF-1R signaling and, as a result, accelerated migration and proliferation, particularly in the presence of excess glucose. We propose that GM3S and GM3 are key molecules in the development of insulin resistance and potential targets for therapies to improve diabetic wound healing.
RESULTS

Increased expression of GM3S in human and mouse diabetic skin
Human diabetic foot skin had a 4.1-fold increase in GM3S mRNA expression in comparison with age-and site-matched controls (Figure 1a ). In the skin of two diabetic mouse models, ob/ob (leptin deficient) and C57BL/6 mice fed a high-fat diet (HFD) for 10 weeks (DIO), GM3S mRNA expression was increased by 4.2-fold and 3.0-fold, respectively (Figure 1b) , and GM3 by 2.8-and 2.6-fold, respectively (Figure 1c ). GM3 and GM3S were virtually undetectable in GM3S −/− mouse skin.
GM3S depletion reverses the wound healing defect in DIO mice
To explore the effect of GM3S expression on wound healing in vivo, we compared the wound healing of GM3S −/− and GM3 +/+ littermate (WT) mice. Initially we confirmed the partial prevention of insulin resistance in GM3S −/− mice fed a HFD for 10 wks as previously described (Yamashita et al., 2003) (Supplemental Figure 1) . GM3S −/− HFD mice were as obese as their WT HFD littermates and showed high mean fasting glucose levels, but had normal fed insulin and glucose levels at 120 min after glucose challenge.
To more closely simulate human wound healing and reduce mouse skin contraction, we used a silicone splinted wound healing model (Galiano et al., 2004) , which allows healing primarily by re-epithelialization. Wound closure was visibly delayed in WT HFD mice by 5 days after wound initiation (Figure 2a and b) , but wound closure in GM3S −/− HFD and RD mice was similar. By only 3 days after wounding, the epidermal gap was greater in WT HFD vs. other mice, including GM3S −/− HFD mice (Figure 2c , p<0.05) and increased progressively (p<0.001 for 5 and 7 days). Full epidermal closure required 14.1 days in WT HFD mice, but 7.4 days in GM3S −/− HFD mice, and the rate was equal at all time points for GM3S −/− HFD, GM3S −/− RD, and WT RD mice (Figure 2c ). Granulation tissue area was smaller in WT HFD wounds than in wounds from GM3S −/− HFD mice (Figure 2d , p<0.05 at 5 d and p<0.001 at 7 d; Supplemental Figure 2 ), but the same in WT RD and GM3S −/− HFD mouse wounds. WT HFD epidermis on day 3 wounds had fewer bromodeoxyuridinepositive (BrdU+) proliferating basal KCs (p<0.05; Figure 2e ) and a smaller migrational distance (p<0.05; Figure 2f ) than other mouse epidermis. These studies suggest that the accelerated wound healing in vivo, at least in part, is related to the observed increase in both keratinocyte proliferation and migration. Immunohistochemical analyses show that GM3S knockout reversed the deficit in p-IGF-1R staining seen in WT HFD mouse wound skin (Supplemental Figure 3) .
Increased glucose exposure stimulates GM3S −/− KC migration and proliferation
Pre-incubation of WT primary mouse KCs in 20 mM glucose for 72 h, traditionally used to simulate the hyperglycemic diabetic environment in vitro (Ingram et al., 2008; Suzuki et al., 2011) , stopped migration in in vitro wounds (Figure 3a and b) and reduced cell proliferation ( Figure 3c ) (Lan et al., 2008; Spravchikov et al., 2001; Terashi et al., 2005) . GM3S −/− cells migrated faster than WT cells by 24 h after wounding in normoglycemic conditions. In hyperglycemic medium, GM3S −/− KCs closed wounds (Figure 3a and b) and proliferated faster ( Figure 3c ) than GM3S −/− in normoglycemic medium or WT cells in normoglycemic or hyperglycemic medium. Addition of supplemental GM3 eliminated the protective effect of GM3S depletion on glucose-induced suppression of migration and proliferation; no statistically significant difference was found when GM3S −/− vs. WT KCs were treated with the combination of GM3 and high glucose at any time point (Figure 3a-c) . In WT KCs, high glucose increased expression of GM3, as shown by immunofluorescence ( Fig. 3d) and GM3S, as shown by Western blotting (Fig. 3e) . Addition of the GM3 metabolic precursor lactosylceramide (LacCer), which is increased in GM3S knockout cells (Supplemental Figure 4a ), did not affect WT KC proliferation (Supplemental Figure 4b ) and decreased cell migration (Supplemental Figure 4c and d). These findings suggest that the increase in keratinocyte migration and proliferation, particularly with high glucose exposure, results directly from depletion of GM3 and not of increased LacCer. Figure  4a 
GM3S depletion activates IR and IGF-1R signaling-GM3S depletion dramatically increased IR and IGF-1R phosphorylation and downstream activation, as shown in
GM3S depletion increases the association of IR, IRS-1, and IGF-1R
In KCs, activation of IR or IGF-1R promotes their association with insulin receptor substrate 1 (IRS-1) (Sadagurski et al., 2007) , thereby activating IRS-1, phosphatidylinositol 3-kinase (PI3K), AKT, and other downstream pathway components. As expected, stimulation of WT KCs with insulin or IGF-1 led to the association of IRS-1 with IR ( Figure 4c (Figure 4c , rows 3 and 6, lanes 10-11 vs. 3-4), but was maintained or increased by up to 2-fold in GM3S −/− cells (Figure 4c , rows 3 and 6, lanes 12-14 vs. 5-7).
GM3S depletion activates IRS-1 and downstream signaling
Increased glucose inhibited insulin-and IGF-1-induced p-IRS-1 in WT cells by 100% and 20%, respectively (Figure 4d , bottom row, lanes 10-11 vs. 3-4). GM3S depletion led to a 4-fold increase in p-IRS-1 (Figure 4d , bottom row, lanes 6-7 vs. 3-4), which more than doubled under hyperglycemic conditions (Figure 4d , bottom row, lanes 13-14 vs. 6-7). 
IGF-1R is critical for the accelerated migration of GM3S −/− KCs
Finally, we addressed the relative importance of IR vs. IGF-1R activation in stimulating GM3S −/− KC migration. Small molecule inhibitors of IR were non-specific and inhibited IGF-1R, whereas the IGF-1R inhibitor AG538 did not inhibit IR phosphorylation. As a result, we transiently transduced an IR shRNA lentivirus into WT and GM3S −/− mouse KCs, which knocked down IR by 55% and reduced p-IR by 87% in comparison with untreated and control shRNA-transduced cells, but did not alter IGF-1R expression (Figure 5a ) or phosphorylation. AG538, in contrast, suppressed IGF-1R activation by 95% without affecting expression or phosphorylation of IR (Figure 5b) . To be able to compare the impact of inhibitors on WT vs. GM3S −/− cells in normal glucose vs. GM3S −/− cells in high glucose, scratch assays were performed with all cell types and conditions in parallel. Treatment of WT cells with IR shRNA, AG538, or LY294002 (which inhibits downstream PI3K) reduced in vitro wound closure after 60 h by about 50%, while treatment with the combination of IR shRNA+AG538 decreased migration to the same extent as GM3 (50 μM), supplemental glucose, or IR sh/AG538 with or without GM3 or glucose (all 70%) (Figure 5c , Supplemental Figure 6 ). In contrast, IR shRNA reduced migration after 60 h of the GM3S −/− KCs without extra glucose by only 26%, while AG538, the combination of IR shRNA +AG538, GM3, and LY294002 similarly reduced migration by approximately 56% (Figure  5d ; Supplemental Figure 6 ). In the presence of supplemental glucose (G), GM3S −/− KC migration was accelerated. As in GM3S −/− KCs grown without high glucose, IR shRNA only reduced migration by 27%; however, AG538 alone, LY294002, AG538+IR shRNA, GM3, and the combination of AG538+IR shRNA+GM3 all reversed the stimulatory effect on migration of GM3S −/− KCs in high glucose beginning 24 h after the scratch (and by 60-65% at 60 h). Treatment of GM3S −/− KCs in high glucose with both inhibitors or GM3 suppressed migration to the same extent as WT KCs treatment with GM3 and AG538+IR shRNA (Figure 5e ; Supplemental Figure 6 ). These data provide further evidence of a key role for activation of IGF-1R signaling in accelerated wound healing in GM3S −/− HFD mice.
DISCUSSION
Despite intriguing evidence that GM3 is a key intermediary in the development of insulin resistance in canonical insulin target tissues, the effect of GM3 depletion on peripheral tissues and diabetic wound healing has never been explored. We now show that GM3S depletion fully reverses the impairment in wound healing in a DIO diabetic mouse model, despite mouse obesity and only partial improvement in systemic glucose homeostasis. In this model, increases in both migration and proliferation of KCs contribute to the accelerated healing (Seitz et al., 2010) . Furthermore, we have demonstrated a direct effect of GM3S depletion on KC motility and proliferation in vitro through activation of insulin/IGF-1 axis signaling.
This stimulatory effect of GM3S depletion on KC motility and proliferation is intensified when KCs are made "diabetic" through exposure to increased glucose, as opposed to the marked inhibition of WT KC migration and proliferation by supplemental glucose. In other studies, we have found that accumulation of GM3 through gene suppression of enzymes regulating GM3 metabolism suppresses KC migration and proliferation (unpublished data, ASP); coupled with the lack of stimulation of KC migration and proliferation by LacCer, the GM3S substrate, these data implicate depletion of GM3 itself as the cause of the stimulatory effects of GM3S knockdown. Furthermore, these observations suggest a central role for KC GM3 in the wound healing defect of obesity-related diabetes (see schematic, Supplemental Figure 6 ). now shown that GM3 depletion increases IR sensitivity in KCs not only to insulin but also to IGF-1. Importantly, we have demonstrated that GM3 affects IGF-1R signaling, which to our knowledge is previously unreported. At least in KCs, the impact on IGF-1R appears to be more significant in controlling cell migration than the effect on IR. Indeed, IGF-1, which is produced by dermal fibroblasts, stimulates KC proliferation (Ando and Jensen, 1993; Haase et al., 2003) and accelerates in vitro (Haase et al., 2003) and in vivo (Jeschke et al., 2004; Jyung et al., 1994; Semenova et al., 2008) wound healing. mIGF-1 transgenic mice have a hyperplastic epidermis and accelerated wound healing (Semenova et al., 2008) , while IGF-1R −/− mice show skin hypotrophy and delayed wound healing (Liu et al., 1993) . Diabetic wounds are deficient in IGF-1 (Blakytny et al., 2000) and, as we have now demonstrated, decreased in IGF-1R activation. In other studies, we have also found decreased p-IGF-1R, p-IR, and pSer 473 -Akt expression by Western blotting in the wounds of WT HFD mice, but not GM3S −/− HFD or WT RD mice (data not shown). The prevention of hyperglycemia-induced suppression of IR and IGF-1R signaling, migration, and proliferation by GM3S depletion, and its reversal when exogenous GM3 is added, further suggest that GM3 is a key mediator of insulin resistance.
Gangliosides are thought to impact signaling primarily at the membrane level through regulating interactions of lipid raft components (Sonnino and Prinetti, 2010) . Although IR and IGF-1R localization in primary KC membranes is not defined, both receptors signal in caveolar lipid rafts in other cell types (Kabayama et al., 2007; Romanelli et al., 2009; Sekimoto et al., 2012) , and IGF-1R signaling requires caveolin-1 in keratinocyte-derived HaCaT cells (Salani et al., 2010) . In adipocytes, increases in membrane GM3 content by chronic exposure to low concentrations of TNF-α, prevents the localization of IR to caveolar domains (Kabayama et al., 2005; Kabayama et al., 2007; Sekimoto et al., 2012) . When GM3 content is reduced, IR accumulates in these lipid raft domains, associates to a greater extent with caveolin-1, and is activated (Kabayama et al., 2005) . Ganglioside depletion may similarly prevent IR, and possibly IGF-1R, from leaving caveolar domains in KCs, leading to increased receptor activation and downstream signaling.
MATERIALS & METHODS (see Supplemental Methods)
Mouse models, human diabetic skin, and cultured mouse keratinocytes Human diabetic and age-matched volunteer control plantar foot skin was obtained after written Northwestern IRB-approved informed patient consent according to Declaration of Helsinki guidelines; adipose tissue was removed prior to analyses. Mouse studies were approved by Northwestern's Animal Care and Use Committee. Male GM3S −/− mice (Yamashita et al., 2003) and wildtype (WT) GM3S +/+ littermate mice were fed a regular (RD) or 42% high fat diet (HFD) for 10 weeks and throughout analyses. ob/ob mice were from Jackson Labs. Mouse KCs were isolated from GM3S −/− or WT skin at 1 day of age (Hamill et al., 2012) and were used at passages 2-3.
Glucose tolerance tests and insulin measurement
Glucose tolerance testing (GTT) and fed insulin measurements were performed after 10 wks on a RD or HFD and at least 1 wk before wounding studies.
Detection of GM3 and gene expression in skin and KCs
Total ganglioside was extracted (Wang et al., 2001 ) from mouse skin. GM3 expression was determined by thin-layer chromatography immunostaining using anti-GM3 antibody with loading normalized to cell number and densitometry to quantify (DH2, Glycotech, Gaithersburg, MD) (Wang et al., 2002) ; the same antibody was used with FITC secondary antibody to detect GM3 by immunofluorescence. Gene expression of mouse GM3S, IR, IGF-1R, and IRS-1 was assessed on extracted total RNA by qRT-PCR and of human foot skin GM3S by droplet digital PCR (ddPCR) (see Supplemental Table 1 and Methods).
In vivo wound healing analysis
5 mm wounds were made on each side of the dorsal midline to below the panniculus carnosus and a donut-shaped silicone splint with a 6 mm inner circle was adhered to the surrounding skin to prevent contracture (Galiano et al., 2004) . Wound closure was analyzed at days 3, 5, 7, and every 3 days until healed by standardized photography and digital imaging. Wounds were harvested on days 3, 5, and 7, and processed for histologic, immunohistochemical, and RNA expression studies. All histological analyses to determine epidermal gap and granulation tissue area and immunohistochemical studies were performed at Northwestern's Skin Disease Research Center.
In vitro proliferation and migration assays
To simulate hyperglycemia, mouse KC medium (8 mM glucose) was supplemented with 12 mM glucose (Sigma, St. Louis, MO) for 72 h. Proliferation (measured by Water Soluble Tetrazolium assay) and cell migration (by scratch assays in the presence of mitomycin C) (Wang et al., 2003) were performed in: a) WT KCs pretreated for 72 h with LacCer (5 μM, Matreya LLC, Pleasant Gap, PA) (Mu et al., 2009) ; b) GM3S −/− KCs pretreated for 48 h with GM3 (50 μM, Matreya) (Paller et al., 1993) ; c) GM3S −/− and WT cells pretreated 24h with IGF-1R-specific inhibitor AG538 (4 μM, CalBiochem, Billerica, CA) or PI3K inhibitor LY294002 (20 μM, CalBioChem, Billerica, MA); or d) GM3S −/− and WT cells transduced with IR sh RNA or its vector control (Santa Cruz, CA) for 72 h.
Immunoblotting and immunoprecipitation
Immunoblotting was performed (Wang et al., 2003) to detect IR, IGF-1R, IRS-1, Akt, GM3S, p-IR, p-IGF-IR, p-IRS-1, p-Ser473 Akt, and PY-20. Primary mouse KCs were treated with or without supplemental glucose in complete medium for 72 h. Cells were then starved of growth supplements and stimulated with or without insulin (5 μg/mL, Sigma) for 15 mins or IGF-1 (100 ng/mL, Prospect, East Brunswick, NJ) for 30 mins. Selected times represent maximal stimulation times for each growth factor based on preliminary studies with exposure times of 5, 15, 30 and 60 mins; each was performed 3-5 times. Immunoprecipitation of IR, IGF-1R and IRS-1 were performed as previously described (Wang et al., 2007) with IgG as a negative control.
Statistical analysis
Statistical significance of mouse wound healing data was determined by ANOVA followed by Fisher's least significant difference post-hoc testing for individual comparisons; data at each time point was expressed as means±S.E. Mouse skin qRT-PCR and thin-layer chromatography data, as well as BrdU tissue labeling data, were expressed as means ± S.D. In vitro KC results and analyses of mouse skin for GM3 and GM3S expression were analyzed by paired Student's t-test, and expressed as mean±S.D. p<0.05 was considered significant.
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